Submissions

Author Guidelines

1. All communications should be directed to the Editor BJMS at the following address:

Editor
Bangladesh Journal of Medical Science
Ibn Sina Trust
1/1-B, Kallyanpur, Mirpur, Dhaka-1216.
Bangladesh.
Email: kholdun@hotmail.com
Tel: 88-02-9010396, Fax: 88-02-9005595.

Submission of manuscript
2. Three copies of the manuscript and a compact disk should be submitted. Each disk must be labeled with the following: Date, Name of primary author, and title of the article.

3. Submission on email instead of disk is allowed. The email address is kholdun@hotmail.com. Email submission should follow submission of three copies by post. Online submission is possible through http://banglajol.info/index.php/BJMS.

4. Submission of a paper to the journal will imply that it represents an original contribution not previously published (except in the form of an abstract or preliminary report), not being considered for publication elsewhere and if accepted by the journal it will not be published elsewhere in the same form without the consent of the editors. (Authors have to declare originality of their work and transfer of copyright to BJMS authority using prescribed format.)

5. One free reprint will be supplied to the senior/corresponding author. Copies can be obtained at a reasonable cost for a minimum of 20, if ordered at acceptance for publication.

6. Color photograph charges. Author(s) may have to pay extra charges for coloured pages.

7. Ethical approval:

Authors should explicitly mention about the ethical approval of their work by concerned authorities.

Manuscripts based on the study involving human subjects should have been conducted in accordance to the ethical standards laid down in the 1964 Declaration of Helsinki revised in the year 2000.

Studies involving trial on animals should also get appropriate ethical approval.

Authors should disclose conflict of interest if it is there.

Informed Consent Guidelines: The research article related to clinical trial must have a statement that an informed consent document was filled-up by the volunteer/patient. The subjects in the study must participate willingly, having been adequately informed about the research. In case of children, the researcher must first obtain the permission of parents in addition to the consent of the children. Informed consent documents should be written at a level appropriate to the subject population, generally at an 8th grade reading level. A best practice is to have a colleague or friend read the informed consent document for comprehension before submission with the IRB application.

Gender Policy: Authors should disaggregate data by sex and provide gender analysis when applicable.

Anti-plagiarism policy: Any manuscript if proven copying or having tendency to plagiarism will be reported to proper authority.

Proofs: All proofs must be corrected and returned to the publisher as early as possible. Only correction of typographical errors is permitted at the proof stage.

Authorship: The corresponding author is responsible for all the information of these forms. He/she will confirm that all the authors have read the manuscript before submission. The following person(s) will be authors:

concept. research question and study design
data collection or processing

Any person only involved in writing the manuscript or analyzing the data will not be the author or corresponding author particularly in Research Article.

Conflict of interest: All authors of the submitted manuscript are requested to disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations within two years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work.

Organization of manuscript

8. Original articles are usually up to 3,000 words and review articles 4,500 words long, with least number of illustrations and/or tables. Short communication/case reports are up to 1,500 words long, with a few tables or illustrations and no more than 10 references. Most editorials are solicited, but we are delighted to consider unsolicited editorials of usually up to 1,000-1,500 words which will be externally peer reviewed.

9. Contributions for the Personal view column are always welcome and should contain up to 2,500 words. Letters to editors should normally be of not more than 1,500 words, with not more than five references. We also receive book review/article review/electronic media review and conference report within 400-800 words and 1000 words respectively. Justified comments on any published article in BJMS are also acceptable.

10. Submissions should be accompanied by a letter listing (i) full name with surname in bold font, (ii) affiliations & address of the authors with identification of the author to receive correspondence and proofs. (A corresponding author's name, address, phone number and email must be specified in the letter.) and (iii) authors undertaking.

11. Manuscripts should be double spaced in between lines and numbered sequentially in the lower middle place on A4 paper..

12. Headlines:Headlines should start with a capital initial and distinguishable according to hierarchy, e.g.

big heads in bold font & underlined, followed by
secondary heads in bold & italic letters, and
subsequent heads underlined.

13. Papers submitted should be concise and written in English in a readily understandable manner and otherwise may be rejected. The typescript, where possible, should follow the conventional form: introduction, materials and methods, results, discussion and conclusion. (When describing any drugs used, give generic names rather than trade names.).

14. A structured abstract as appropriate should be provided with the following:

Objective: An introductory sentence indicating the objective and purpose of the study.
Materials and methods: A description of experimental procedures including applicable statistical evaluation.
Results and Discussion: A summary of the new, previously unpublished data and results.
Conclusion: A statement of the study's conclusion.

15. 3-5 key words (in small letters) as well as a short title (not exceeding 50 letters) must be provided. These will be printed at the beginning of the paper.

16. Tables and figures should be so constructed as to be intelligible without reference to the text. The approximate location of tables and figures in the text must be clearly indicated. Every table should be provided with an explanatory caption, and each column should carry an appropriate heading.

17. Illustrations should accompany the manuscript on a separate sheet, and legends should include all relevant details. All photographs, charts and diagrams should be referred to as Figures and numbered consecutively in the order in which they are first referred to in the text.

18. Owing to the international character of the journal no rigid rules will be observed for nomenclature. Each paper should be consistent within itself as to nomenclature, symbols and units.

19. All manuscripts will be assessed through the normal refereeing process. Most manuscripts accepted for publication require some revision, details of which are sent to authors. The final decision with regard to publication will be made following consultation with our publisher, Ibn Sina Trust.

20. Acknowledgements should appear on a separate sheet at the end before the section on References.

Referencing

References should follow methods written below.

References are numbered in the order in which they appear in the text. At the end of the article the full list of references should give the names and initials of all authors (unless there are more than six, when only the first six should be given followed by et al). The authors' names are followed by the title of the article; the title of the journal abbreviated according to the style of Index Medicus (see "List of Journals Indexed," printed yearly in the January issue of Index Medicus); the year of publication; the volume number; issue number in parenthesis and the first and last page numbers. References to books should give the names of editors, the title of the book, and place of publication, publisher and year. Examples:

1. Journal

Standard Journal Article
Mafauzy M, Mokhtar N, Wan Mohamad WB and Musalmah M. Diabetes Mellitus and associated cardiovascular risk factors in Nort-East Malaysia. Asia Pac J Public Health 1999;11 (1):16-19

Corporate author
International Steering Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals. BMJ 1991; 302: 338-41.

2. Books and other monographs

Personal author(s)
OConnor M, Woodford FP, Writing Scientific Papers in English, an EISE-Ciba Foundation Guide for Authors. London: Pitman Medical, 1978

Chapter in a book
Park JE, Park K. Environment and Health. In Hamilton P, ed. Textbook of Preventive and Social Medicine. 12th ed. New Delhi, Banarsidas Bhanot, 1989:357-372.

These instructions are confronting with the guidelines of International Committee of Medical Journal Editors (ICMJE); please visit http://www.icmje.org.

______________

Authors Undertaking

(Should be signed by all authors)

Reference: Manuscript entitled: ____________________

Author(s) ______________________________________________

Submitted for publication in the journal:

BANGLADESH JOURNAL OF MEDICAL SCIENCE

Conditions of Submission:

Copyright: Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.

Licensing:

Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.

Ownership Rights: All proprietary rights other than copyright (such as patient rights) are reserved to the authors, this include the right to reproduce original figures and tables from this item in their future works, provided full credit is given to the original publication.

Originality: The authors assures that this submission is an original work and that neither this work nor one with substantially similar content has been published elsewhere in whole or in part (except in abstract form), that it has only been submitted for this publication, and that it will not be submitted elsewhere pending written notice of acceptance or rejection by this journal (Please express explicitly if you have the plan to publish any more article based on partial data of this work).

Declaration of authorship: The undersigned certify that all authors have participated sufficiently in the conception and design of this work and the analysis of the data (when applicable), as well as the writing of the manuscript to take public responsibility for it. The undersigned believe the manuscript represents valid work and have reviewed the final version of the manuscript and approve it for publication.

Data availability: The undersigned attest that they shall produce the data upon which the manuscript is based for evaluation by the Editors of their assignees should it be requested.

Disclaimer: The undersigned assures that the manuscript contains no libelous or unlawful statements and does not infringe on the rights of others. If excerpts (text or artwork) from copyrighted works are included, written permission will be secured by the authors and proper credit will be shown in the manuscript.

Initial Internal Editorial Review

Any article received is first examined by executive editor or his staffs. It helps to prevent unnecessary delay in review process. Early rejection helps the author to refine their article and resubmit in BJMS or to choose other journal. This initial review usually takes about one week. If the Submitted manuscript fits with journal’s scope and standard then we send the article for External review.

External Review

If any manuscript passes the ‘Initial Internal Editorial Review‘ then we send it to the peer reviewers.

Editorial Decision after external review

If the reviewers reject it we reject it.
If the reviewers give any correction/modification plan we communicate the author to redo and resubmit his manuscript. After re-submission we check whether their re-submission fulfills reviewer’s satisfaction.
If all these steps are successfully completed then we send it for publication.
We have additional statistical reviewers. We use their expertise if the manuscript deserves their review.
At least two reviewers per article is assigned by the journal authority.
Duration of review process: Review process takes around two weeks to three months time.
All the process is double blind author never knows the reviewers and vice versa.

Submission Preparation Checklist

All submissions must meet the following requirements.

The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
The submission file is in Microsoft Word, RTF, or WordPerfect document file format.
Where available, URLs for the references have been provided.
The text is double-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.
If submitting to a peer-reviewed section of the journal, the instructions in Ensuring a Blind Review have been followed.

Copyright Notice

Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:

Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.
Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.

Privacy Statement

Bangladesh Journals Online (BanglaJOL) is a member of the Ubiquity Partner Network coordinated by Ubiquity Press. According to the EU definitions, BanglaJOL is the data controller, and Ubiquity Press are the service providers and data processors. Ubiquity Press provide the technical platform and some publishing services to BanglaJOL and operate under the principle of data minimisation where only the minimal amount of personal data that is required to carry out a task is obtained.

More information on the type of data that is required can be found in Ubiquity Press’ privacy policy below.

Ubiquity Press Privacy Policy

We take seriously our duty to process your personal data in a fair and transparent way. We collect and manage user data according to the following Privacy Policy. This document is part of our Terms of Service, and by using the press portal, affiliated journals, book, conference and repository websites (the “Websites”), you agree to the terms of this Privacy Policy and the Terms of Service. Please read the Terms of Service in their entirety, and refer to those for definitions and contacts.

What type of personal data do we handle?

There are four main categories of personal data stored by our journal platform, our press platform, and our book management system; Website User data, Author data, Reviewer data and Editor data.

The minimum personal data that are stored are:

full name
email address
affiliation (department, and institution)
country of residence

Optionally, the user can provide:

salutation
gender
associated URL
phone number
fax number
reviewing interests
mailing address
ORCiD
a short biography
interests
Twitter profile
LinkedIn profile
ImpactStory profile
profile picture

The data subjects have complete control of this data through their profile, and can request for it to be removed by contacting info@ubiquitypress.com

What do we do to keep that data secure?

We regularly backup our databases, and we use reliable cloud service providers (Amazon, Google Cloud, Linode) to ensure they are kept securely. Backups are regularly rotated and the old data is permanently deleted. We have a clear internal data handling policy, restricting access to the data and backups to key employees only. In case of a data breach, we will report the breach to the affected users, and to the press/journal contacts within 72 hours.

How do we use the data?

Personal information is only used to deliver the services provided by the publisher. Personal data is not shared externally except for author names, affiliations, emails, and links to ORCiD and social media accounts (if provided) in published articles and books which are displayed as part of the article/book and shared externally to indexes and databases. If a journal operates under open peer review then the reviewer details are published alongside the reviewer details.

How we collect and use your data:

1. When using the website

1.1 what data we collect

When you browse our website, we collect anonymised data about your use of the website; for example, we collect information about which pages you view, which files you download, what browser you are using, and when you were using the site.
When you comment on an article or book using Disqus, we are not collecting, controlling or processing the data. More details on the DISQUS privacy policy can be found on their website.
When you annotate an article or book, this is done via a 3rd party plugin to the website called Hypothes.is. In using this plugin we are not collecting, controlling or processing the data. More details on the Hypothes.is privacy policy can be found on their website.

1.2 why we collect the data

We use anonymised website usage data to monitor traffic, help fix bugs, and see overall patterns that inform future redesigns of the website, and provide reports on how frequently the publications on our site have been accessed from within their IP ranges.

1.3 what we do (and don’t do) with the data

We do not collect personal information that can be used to identify you when you browse the website.
We currently use Google Analytics for publication reports, and to improve the website and services through traffic analysis, but no personal identifying data is shared with Google (for example your computer’s IP is anonymised before transmission).

1.4 what to do if you want to get a copy of your data, or want your data to be removed

Please contact info@ubiquitypress.com to request a copy of your data, or for your data to be removed/anonymised.

2. When registering as an author, and submitting an article or book

2.1 what data we collect

When registering an account we ask you to log in and provide certain personal information (such as your name and email address), and there is the option to register using an ORCiD which will pre-fill the registration form.
As part of submitting an article for publication, you will need to provide personally identifying information which will be used for the peer review process, and will be published. This can include ‘Affiliation’, ‘Competing interests’, ‘Acknowledgements’.

2.2 why we collect the data

Registering an account allows you to log in, manage your profile, and participate as an author/reviewer/editor. We use cookies and session information to streamline your use of the website (for example in order for you to remain logged-in when you return to a journal). You can block or delete cookies and still be able to use the websites, although if you do you will then need to enter your username and password to login. In order to take advantage of certain features of the websites, you may also choose to provide us with other personal information, such as your ORCiD, but your decision to utilize these features and provide such data will always be voluntary.
Personal data submitted with the article or book is collected to allow follow good publication ethics during the review process, and will form part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.

2.3 what we do (and don’t do) with the data

We do not share your personal information with third parties, other than as part of providing the publishing service.
As a registered author in the system you may be contacted by the journal editor to submit another article.
Any books published on the platform are freely available to download from the publisher website in PDF, EPUB and MOBI formats on the publisher’s site.
Any personal data accompanying an article or a book (that will have been added by the submitting author) is published alongside it. The published data includes the names, affiliations and email addresses of all authors.
Any articles published on the platform are freely available to download from the publisher website in various formats (e.g. PDF, XML).
Ubiquity Press books and articles are typeset by SiliconChips and Diacritech.This process involves them receiving the book and book associated metadata and contacting the authors to finalise the layout. Ubiquity Press work with these suppliers to ensure that personal data is only used for the purposes of typesetting and proofing.
For physical purchases of books on the platform Ubiquity Press use print on demand services via Lightning Source who are responsible for printing and distribution via retailers. (For example; Amazon, Book Repository, Waterstones). Lightning Source’s privacy policy and details on data handling can be found on their website.

2.4 why we store the data

We store the account data so that you may choose to become a reviewer and be able to perform those tasks, or to become an author and submit an article and then track progress of that article.
Published personal data that accompanies an article or a book forms part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.

2.5 what to do if you want to get a copy of your data, or want your data to be removed

You are able to view, change and remove your data associated with your profile. Should you choose to completely delete your account, please contact us at support@ubiquitypress.com and we will follow up with your request as soon as possible.
To conform to publication ethics and best practice any personal data that is published alongside an article or book cannot be removed. If you have a query about a publication to which you are attributed please contact info@ubiquitypress.com

3. When registering as a reviewer

3.1 what data we collect

To become a reviewer you must first register as a user on the website, and set your preference that you would like to be considered as a reviewer. No new personal data is collected when a registered user elects to become a reviewer.
When registering an account we ask you to log in and provide certain personal information (such as your name and email address), and there is the option to register using an ORCiD which will pre-fill the registration form.
Reviewers can also be registered by editors who invite them to review a specific article. This requires the editor to provide the reviewer’s First Name, Last Name, and Email address. Normally this will be done as part of the process of inviting you to review the article or book.
On submitting a review, the reviewer includes a competing interest statement, they may answer questions about the quality of the article, and they will submit their recommendation.

3.2 why we collect the data

The data entered is used to invite the reviewer to peer review the article or book, and to contact the reviewer during and the review process.
If you submit a review then the details of your review, including your recommendation, your responses to any review form, your free-form responses, your competing interests statement, and any cover letter are recorded.

3.3 what we do (and don’t do) with the data

This data is not shared publicly and is only accessible by the Editor and system administrators of that journal or press.
The data will only be used in connection with that journal or press.
Data that is retained post final decision is kept to conform to publication ethics and best practice, to provide evidence of peer review, and to resolve any disputes relating to the peer review of the article or book.
For journals or presses that publish the peer reviews, you will be asked to give consent to your review being published, and a subset of the data you have submitted will become part of the published record.

3.4 what to do if you want to get a copy of your data, or want your data to be removed

If you would no longer like to be registered as a reviewer you can edit your profile and tick the box ‘stop being a reviewer’. This will remove you from the reviewer database, however any existing reviews you may have carried out will remain.
If you have been contacted by an editor to peer review an article this means that you have been registered in the system. If you would not like to be contacted for peer review you can reply to the email requesting that your data be deleted.

4. When being registered as a co-author

4.1 what data we collect

Co-author data is entered by the submitting author. The submitting author will already have a user account. According to standard publishing practice, the submitting author is responsible for obtaining the consent of their co-authors to be included (including having their personal data included) in the article/book being submitted to the journal/press.
The requested personal data for co-authors are at the bare minimum; first name, last name, institution, country, email address. This can also include; ORCID ID, Title, Middle Name, Biographical Statement, Department, Twitter Handle, Linkedin Profile Name or ImpactStory ID.

4.2 why we collect the data

Assuming that it is accepted for publication, this data forms part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.
Author names, affiliations and emails are required for publication and will become part of the permanent cited record.

4.3 what we do (and don’t do) with the data

The co-author’s personal data is stored in the author database. This personal data is only used in relation to the publication of the associated article.
Any co-author data collected is added to the author database and is only used in association with the article the user is co-author on.

4.5 what to do if you want to get a copy of your data, or want your data to be removed

To receive a copy of your data, please contact info@ubiquitypress.com
To conform to publication ethics and best practice any personal data that is published alongside an article or book cannot be removed. If you have a query about a publication to which you are attributed please contact info@ubiquitypress.com

5. When signing-up to receive newsletters

5.1 what data we collect

We require you to include your name and email address

5.2 why we collect and store the data, and for how long

This data would be collected to keep you updated with any news about the platform or specific journal

5.3 what we do (and don’t do) with the data

We use mailchimp to provide our mailing list services. Their privacy policy can be found here

5.4 what to do if you want to get a copy of your data or want your data to be removed

All emails sent via our newsletter client will include a link that will allow you to unsubscribe from the mailing list

Notification about change of ownership or of control of data

We may choose to buy or sell assets. In the case that control of data changes to or from Ubiquity Press and a third party, or in the case of change of ownership of Ubiquity Press or of part of the business where the control of personal data is transferred, we will do our best to inform all affected users and present the options.

(Updated: 18 May 2018)